1,2-annelated quinoline derivatives
CA 2355717 C · Owner: Venet, Marc Gaston · Inventors: Venet, Marc Gaston; Bourdrez, Xavier Marc; Angibaud, Patrick Rene
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention concerns , compounds of formula (I), the pharmaceutically , acceptable acid addition salts and the stereochemically , isomeric forms thereof wherein -X1-X2-X3- is a , trivalent radical; >Y1-Y2- is a trivalent radical; r and s are each independently , 0, 1, 2, 3, 4 or 5; t is 0 1, 2 or 3; each R1 and R2, are independently hydroxy halo, cyano, C1-6alkyl, trihalomethyl, trihalomethoxy C2-6alkenyl, C1-6alkyloxy, hydroxyC1-6alkyloxy C1-6alkylthio, C1-6alkyloxyC1-6alkyloxy C1-4alkyloxycarbonyl, aminoC1-, 6alkyloxy mono- or di(C1-6alkyl)amino, mono- or di(C1-6alkyl)aminoC1-6alkyloxy, aryl, arylC1-6alkyl aryloxy or arylC1-, 6alkyloxy, hydroxycarbonyl C1-6alkyloxycarbonyl; or two …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 17, 1999 and granted February 8, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 17, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 17, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.